Dynavax: Earnings This Year Ought To Surprise To The Upside
FG Trade/E+ via Getty Images
Investment Thesis
Dynavax’s (DVAX) Q221 earnings are due in 4 days and there are reasons to be optimistic that the company can build on a blowout Q121, in which the vaccine and adjuvant developing biotech reported revenues…
